At baseline n = 200 | At 2 years of follow-up n = 200 | P-values | |
---|---|---|---|
Age | 63.3 ± 9.7 | 65.5 ± 9,8 | |
Smoker | 45 (22.5) | 25 (12.5) | < 0.001 |
Overweight* | 129 (65.5) | 144 (72) | < 0.001 |
Systolic BP (mmHg) | 146.8 ± 23.4 | 137.5 ± 18.0 | < 0.001 |
Diastolic BP (mmHg) | 91.3 ± 15.0 | 79.6 ± 10.3 | < 0.001 |
Heart rate (beats/min) | 75.6 ± 18.8 | 62.1 ± 10.6 | < 0.001 |
Hypertension | 102 (51.0) | 123 (63.4) (n = 194)# | 0.157 |
Hyperlipidemia | 53 (26.5) | 115 (63.5) (n = 181)# | 0.209 |
Diabetes type1/type2 | 26 (13.0) | 43 (21.8) (n = 197)# | 0.259 |
Heart failure | 6 (3.0) | 14 (7) | < 0.001 |
Atrial fibrillation | 8 (4.0) | 29 (14.8) (n = 196)# | 0.439 |
Stroke or TIA | 12 (6.0) | 14 (7.2) (n = 194)# | 0.319 |
Renal failure | 4 (2.0) | 9 (4.5) | < 0.001 |
Aspirin | 199 (99.5) | 183 (91.5) (n = 199)# | 0.774 |
Betablockers | 187 (93.5) | 166 (84.3) (n = 197)# | 0.452 |
Statins | 193 (96.5) | 177 (89.4) (n = 198)# | 0.628 |
ACE-inhibitors or ARB | 177 (88.5) | 153 (76.5) | 0.463 |